RE: promate 2g approved18 Feb 2022 13:46
SPQ, I agree with most of your post, but even if certain things are ‘priced in’ at some point, that makes no difference to a sentiment driven share, especially one that’s also being manipulated. The Covid fundamentals of the business drove things up when in the thick of the pandemic. Rightly or wrongly, the market is now seeing the pandemic in it’s rear view mirror, that means any big changes in SP (and it can surely only move one way!) will be driven by projected post Covid fundamentals - a huge change. So, we’re at the point where the vast majority of our business comes from Covid testing, but we’re being priced as if that was stripped out - hence the MC hovering around cash at bank levels. No matter what happens to our Covid sales, and unless there is a huge sentiment swing back to Covid stocks (unlikely), then this is our new reality.
We either need to present a compressive forward plan, post Covid, or we need to see some big M&A activity taking place (that could be either way). Until we see something along these lines, I can’t see any big moves, just smallish fluctuations - which don’t really bother me either way.